• Tue, May 28, 2024
Annabel Samimy Downgraded (CALT) to Hold and Decreased Target to $40 on, May 28th, 2024
Annabel Samimy of Stifel, Downgraded "Calliditas Therapeutics AB (publ)" (CALT) to Hold and Decreased Target from $55 to $40 on, May 28th, 2024.
Annabel, nor any peers, have made any analyst calls on CALT in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30